|
Age
|
52.5 ± 14.2
|
50.9 ± 11.8
|
53.9 ± 15.9
|
NS
|
|
Women (n [%])
|
152 (80)
|
74 (82)
|
78 (79)
|
NS
|
|
Disease duration (years)
|
10.6 ± 9.0
|
10.2 ± 9.1
|
10.9 ± 8.9
|
NS
|
|
Patients on steroids (n [%])
|
118 (62)
|
56 (62)
|
62 (63)
|
NS
|
|
Mean dose steroids (mg/day)
|
5.30 ± 5.79
|
5.40 ± 5.75
|
5.26 ± 5.83
|
NS
|
|
DAS28 score
|
5.17 ± 1.07
|
5.37 ± 0.94
|
5.00 ± 1.15
|
NS
|
|
Patients on biphosphonates (n [%])
|
35 (19)
|
15 (17)
|
20 (20)
|
NS
|
|
Calcaemia (mmol/l)
|
2.28 ± 0.13
|
2.32 ± 0.12
|
2.24 ± 0.12
|
NS
|
|
Alkaline phosphatase (U/l)
|
74.6 ± 25.6
|
77.5 ± 29.5
|
72.0 ± 21.2
|
NS
|
|
Osteocalcin (ng/ml)
|
19.9 ± 11.8
|
18.4 ± 9.7
|
21.2 ± 13.4
|
NS
|
|
CTX-I (pg/ml)
|
446 ± 307
|
482 ± 386
|
418 ± 227
|
NS
|
|
Parathyroid hormone (pg/ml)
|
30.5 ± 17.6
|
28.7 ± 15.4
|
32.0 ± 19.1
|
NS
|
|
25-hydroxycholecalciferol (ng/ml)
|
19.7 ± 10.3
|
18.2 ± 10.1
|
21.2 ± 10.4
|
NS
|
|
Femoral neck BMD (g/cm2)
|
0.801 ± 0.159
|
0.807 ± 0.156
|
0.797 ± 0.162
|
NS
|
|
Lumbar BMD (g/cm2)
|
0.911 ± 0.143
|
0.930 ± 0.142
|
0.896 ± 0.142
|
NS
|
|
Patients with neck osteopenia (n [%])
|
96 (51)
|
47 (52)
|
49 (50)
|
NS
|
|
Patients with lumbar osteopenia (n [%])
|
93 (49)
|
40 (45)
|
53 (54)
|
NS
|
|
Patients with neck osteoporosis (n [%])
|
37 (20)
|
18 (20)
|
19 (19)
|
NS
|
|
Patients with lumbar osteoporosis (n [%])
|
37 (19)
|
15 (17)
|
23 (23)
|
NS
|
